Recent advances in understanding contextual TGFβ signaling

F1000Research

Volumn 6, Issue , 2017, Pages

  Attisano, Liliana ^b   Ayyaz, Arshad ^a   Wrana, Jeffrey L ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cancer; Cancer associated stroma; Glioma; Hematopoiesis; Hippo pathway; Immunity.; Stem cells; TGF signalling

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR 1; APC PROTEIN; B RAF KINASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; G PROTEIN COUPLED RECEPTOR; GROWTH DIFFERENTIATION FACTOR; HEAT SHOCK TRANSCRIPTION FACTOR 1; HISTONE H3; KRUPPEL LIKE FACTOR 5; METHIONINE; PDZ PROTEIN; PROTEIN NODAL; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; WNT5A PROTEIN;

AUTOCRINE EFFECT; CANCER PROGNOSIS; CANCER SUSCEPTIBILITY; COLON CANCER; EMBRYO DEVELOPMENT; GENE DUPLICATION; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GLIOMA; HEMATOPOIESIS; HUMAN; IMMUNITY; IMMUNOREGULATION; INTESTINE EPITHELIUM; INTESTINE RESECTION; MECHANOTRANSDUCTION; NERVOUS SYSTEM DEVELOPMENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STROMA; TISSUE REGENERATION; TUMOR ASSOCIATED STROMA;

EID: 85024491073     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.11295.1     Document Type: Review

References (94)

1. Huminiecki L Goldovsky L Freilich S : Emergence, development and diversification of the TGF-beta signalling pathway within the animal kingdom. BMC Evol Biol. 2009;9:28. 19192293 10.1186/1471-2148-9-28 2657120
2. Massagué J : TGFβ signalling in context. Nat Rev Mol Cell Biol. 2012;13(10):616-30. 22992590 10.1038/nrm3434 4027049
3. Oshimori N Fuchs E : The harmonies played by TGF-β in stem cell biology. Cell Stem Cell. 2012;11(6):751-64. 23217421 10.1016/j.stem.2012.11.001 3612991
4. Mullen AC Wrana JL : TGF-β Family Signaling in Embryonic and Somatic Stem-Cell Renewal and Differentiation. Cold Spring Harb Perspect Biol. 2017; pii: a022186. 28108485 10.1101/cshperspect.a022186
5. Beyer TA Narimatsu M Weiss A : The TGFβ superfamily in stem cell biology and early mammalian embryonic development. Biochim Biophys Acta. 2013;1830(2):2268-79. 22967760 10.1016/j.bbagen.2012.08.025
6. Morikawa M Derynck R Miyazono K : TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology. Cold Spring Harb Perspect Biol. 2016;8(5): pii: a021873. 27141051 10.1101/cshperspect.a021873 F1000 Recommendation
7. Chen W Ten Dijke P : Immunoregulation by members of the TGFβ superfamily. Nat Rev Immunol. 2016;16(12):723-40. 27885276 10.1038/nri.2016.112 F1000 Recommendation
8. Wakefield LM Hill CS : Beyond TGFβ: roles of other TGFβ superfamily members in cancer. Nat Rev Cancer. 2013;13(5):328-41. 23612460 10.1038/nrc3500
9. Bierie B Moses HL : Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer. 2006;6(7):506-20. 16794634 10.1038/nrc1926
10. Piersma B Bank RA Boersema M : Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge. Front Med (Lausanne). 2015;2:59. 26389119 10.3389/fmed.2015.00059 4558529
11. Lafyatis R : Transforming growth factor β--at the centre of systemic sclerosis. Nat Rev Rheumatol. 2014;10(12):706-19. 25136781 10.1038/nrrheum.2014.137
12. McDonald J Wooderchak-Donahue W VanSant Webb C : Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet. 2015;6:1. 25674101 10.3389/fgene.2015.00001 4306304
13. Akhurst RJ Padgett RW : Matters of context guide future research in TGFβ superfamily signaling. Sci Signal. 2015;8(399):re10. 26486175 10.1126/scisignal.aad0416 F1000 Recommendation
14. Zhang Q Yu N Lee C : Mysteries of TGF-β Paradox in Benign and Malignant Cells. Front Oncol. 2014;4:94. 24860782 10.3389/fonc.2014.00094 4026682 F1000 Recommendation
15. Akhurst RJ : The paradoxical TGF-β vasculopathies. Nat Genet. 2012;44(8):838-9. 22836090 10.1038/ng.2366 3543110
16. Bhatia M Bonnet D Wu D : Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J Exp Med. 1999;189(7):1139-48. 10190905 10.1084/jem.189.7.1139 2193014
17. He XC Zhang J Tong WG : BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet. 2004;36(10):1117-21. 15378062 10.1038/ng1430
18. Khurana S Buckley S Schouteden S : A novel role of BMP4 in adult hematopoietic stem and progenitor cell homing via Smad independent regulation of integrin-α4 expression. Blood. 2013;121(5):781-90. 23243277 10.1182/blood-2012-07-446443
19. Khurana S Melacarne A Yadak R : SMAD signaling regulates CXCL12 expression in the bone marrow niche, affecting homing and mobilization of hematopoietic progenitors. Stem Cells. 2014;32(11):3012-22. 25069965 10.1002/stem.1794 4220608
20. Crisan M Solaimani Kartalaei P Neagu A : BMP and Hedgehog Regulate Distinct AGM Hematopoietic Stem Cells Ex Vivo. Stem Cell Reports. 2016;6(3):383-95. 26923823 10.1016/j.stemcr.2016.01.016 4788785 F1000 Recommendation
21. Blank U Karlsson S : TGF-β signaling in the control of hematopoietic stem cells. Blood. 2015;125(23):3542-50. 25833962 10.1182/blood-2014-12-618090 F1000 Recommendation
22. Weiss A Attisano L : The TGFbeta superfamily signaling pathway. Wiley Interdiscip Rev Dev Biol. 2013;2(1):47-63. 23799630 10.1002/wdev.86
23. Nakao A Afrakhte M Morén A : Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 1997;389(6651):631-5. 9335507 10.1038/39369
24. Parker L Stathakis DG Arora K : Regulation of BMP and activin signaling in Drosophila. Prog Mol Subcell Biol. 2004;34:73-101. 14979665 10.1007/978-3-642-18670-7_4
25. Upadhyay A Moss-Taylor L Kim MJ : TGF-β Family Signaling in Drosophila. Cold Spring Harb Perspect Biol. 2017; pii: a022152. 28130362 10.1101/cshperspect.a022152
26. Daly AC Randall RA Hill CS : Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol Cell Biol. 2008;28(22):6889-902. 18794361 10.1128/MCB.01192-08 2573298
27. Grönroos E Kingston IJ Ramachandran A : Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes. Mol Cell Biol. 2012;32(14):2904-16. 22615489 10.1128/MCB.00231-12 3416179
28. Beumer J Clevers H : Regulation and plasticity of intestinal stem cells during homeostasis and regeneration. Development. 2016;143(20):3639-49. 27802133 10.1242/dev.133132
29. Crosnier C Stamataki D Lewis J : Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat Rev Genet. 2006;7(5):349-59. 16619050 10.1038/nrg1840
30. Qi Z Li Y Zhao B : BMP restricts stemness of intestinal Lgr5+ stem cells by directly suppressing their signature genes. Nat Commun. 2017;8:13824. 28059064 10.1038/ncomms13824 5227110 F1000 Recommendation
31. Barker N Ridgway RA van Es JH : Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 2009;457(7449):608-11. 19092804 10.1038/nature07602 F1000 Recommendation
32. Miyoshi H Ajima R Luo CT : Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. Science. 2012;338(6103):108-13. 22956684 10.1126/science.1223821 3706630 F1000 Recommendation
33. Fischer JM Calabrese PP Miller AJ : Single cell lineage tracing reveals a role for TgfβR2 in intestinal stem cell dynamics and differentiation. Proc Natl Acad Sci U S A. 2016;113(43):12192-7. 27791005 10.1073/pnas.1611980113 5087053 F1000 Recommendation
34. Hong AW Meng Z Guan KL : The Hippo pathway in intestinal regeneration and disease. Nat Rev Gastroenterol Hepatol. 2016;13(6):324-37. 27147489 10.1038/nrgastro.2016.59
35. Perez-Lopez A Behnsen J Nuccio SP : Mucosal immunity to pathogenic intestinal bacteria. Nat Rev Immunol. 2016;16(3):135-48. 26898110 10.1038/nri.2015.17
36. Mowat AM Bain CC : Mucosal macrophages in intestinal homeostasis and inflammation. J Innate Immun. 2011;3(6):550-64. 22025201 10.1159/000329099 3224516
37. Coombes JL Powrie F : Dendritic cells in intestinal immune regulation. Nat Rev Immunol. 2008;8(6):435-46. 18500229 10.1038/nri2335 2674208
38. Neurath MF : Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14(5):329-42. 24751956 10.1038/nri3661
39. Karin M Clevers H : Reparative inflammation takes charge of tissue regeneration. Nature. 2016;529(7586):307-15. 26791721 10.1038/nature17039 5228603 F1000 Recommendation
40. Xavier RJ Podolsky DK : Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448(7152):427-34. 17653185 10.1038/nature06005 F1000 Recommendation
41. Biancheri P Giuffrida P Docena GH : The role of transforming growth factor (TGF)-β in modulating the immune response and fibrogenesis in the gut. Cytokine Growth Factor Rev. 2014;25(1):45-55. 24332927 10.1016/j.cytogfr.2013.11.001 F1000 Recommendation
42. Weaver LN Drummond-Barbosa D : Gut healing: haemocytes aid via Sax and Tkv jazzes it down. Nat Cell Biol. 2015;17(6):707-9. 26022916 10.1038/ncb3178
43. Pull SL Doherty JM Mills JC : Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci U S A. 2005;102(1):99-104. 15615857 10.1073/pnas.0405979102 544052 F1000 Recommendation
44. Travis MA Reizis B Melton AC : Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature. 2007;449(7160):361-5. 17694047 10.1038/nature06110 2670239 F1000 Recommendation
45. Kashiwagi I Morita R Schichita T : Smad2 and Smad3 Inversely Regulate TGF-β Autoinduction in Clostridium butyricum-Activated Dendritic Cells. Immunity. 2015;43(1):65-79. 26141582 10.1016/j.immuni.2015.06.010 F1000 Recommendation
46. Ayyaz A Li H Jasper H : Haemocytes control stem cell activity in the Drosophila intestine. Nat Cell Biol. 2015;17(6):736-48. 26005834 10.1038/ncb3174 4449816
47. Tian A Jiang J : Intestinal epithelium-derived BMP controls stem cell self-renewal in Drosophila adult midgut. eLife. 2014;3:e01857. 24618900 10.7554/eLife.01857 3948108 F1000 Recommendation
48. Pickup MW Owens P Moses HL : TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment. Cold Spring Harb Perspect Biol. 2017;9(5): pii: a022285. 28062564 10.1101/cshperspect.a022285
49. Costanza B Umelo IA Bellier J : Stromal Modulators of TGF-β in Cancer. J Clin Med. 2017;6(1): pii: E7. 28067804 10.3390/jcm6010007 5294960
50. Isella C Terrasi A Bellomo SE : Stromal contribution to the colorectal cancer transcriptome. Nat Genet. 2015;47(4):312-9. 25706627 10.1038/ng.3224 F1000 Recommendation
51. Calon A Lonardo E Berenguer-Llergo A : Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat Genet. 2015;47(4):320-9. 25706628 10.1038/ng.3225 F1000 Recommendation
52. Scherz-Shouval R Santagata S Mendillo ML : The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy. Cell. 2014;158(3):564-78. 25083868 10.1016/j.cell.2014.05.045 4249939 F1000 Recommendation
53. Fessler E Drost J van Hooff SR : TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype. EMBO Mol Med. 2016;8(7):745-60. 27221051 10.15252/emmm.201606184 4931289 F1000 Recommendation
54. Drost J van Jaarsveld RH Ponsioen B : Sequential cancer mutations in cultured human intestinal stem cells. Nature. 2015;521(7550):43-7. 25924068 10.1038/nature14415 F1000 Recommendation
55. David CJ Huang YH Chen M : TGF-β Tumor Suppression through a Lethal EMT. Cell. 2016;164(5):1015-30. 26898331 10.1016/j.cell.2016.01.009 4801341 F1000 Recommendation
56. Zanconato F Cordenonsi M Piccolo S : YAP/TAZ at the Roots of Cancer. Cancer Cell. 2016;29(6):783-803. 27300434 10.1016/j.ccell.2016.05.005
57. Moroishi T Hansen CG Guan KL : The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15(2):73-9. 25592648 10.1038/nrc3876 4562315
58. Attisano L Wrana JL : Signal integration in TGF-β, WNT, and Hippo pathways. F1000Prime Rep. 2013;5:17. 23755364 10.12703/P5-17 3672943
59. Varelas X Sakuma R Samavarchi-Tehrani P : TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol. 2008;10(7):837-48. 18568018 10.1038/ncb1748
60. Varelas X Samavarchi-Tehrani P Narimatsu M : The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway. Dev Cell. 2010;19(6):831-44. 21145499 10.1016/j.devcel.2010.11.012 F1000 Recommendation
61. Beyer TA Weiss A Khomchuk Y : Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells. Cell Rep. 2013;5(6):1611-24. 24332857 10.1016/j.celrep.2013.11.021
62. Mahoney JE Mori M Szymaniak AD : The hippo pathway effector Yap controls patterning and differentiation of airway epithelial progenitors. Dev Cell. 2014;30(2):137-50. 25043473 10.1016/j.devcel.2014.06.003
63. Sun Y Yong KM Villa-Diaz LG : Hippo/YAP-mediated rigidity-dependent motor neuron differentiation of human pluripotent stem cells. Nat Mater. 2014;13(6):599-604. 24728461 10.1038/nmat3945 4051885
64. Yang JY Cho SW An JH : Osteoblast-targeted overexpression of TAZ increases bone mass in vivo. PLoS One. 2013;8(2):e56585. 23441207 10.1371/journal.pone.0056585 3575506
65. Zhang H von Gise A Liu Q : Yap1 is required for endothelial to mesenchymal transition of the atrioventricular cushion. J Biol Chem. 2014;289(27):18681-92. 24831012 10.1074/jbc.M114.554584 4081914
66. Narimatsu M Samavarchi-Tehrani P Varelas X : Distinct polarity cues direct Taz/Yap and TGFβ receptor localization to differentially control TGFβ-induced Smad signaling. Dev Cell. 2015;32(5):652-6. 25758863 10.1016/j.devcel.2015.02.019
67. Yao M Wang Y Zhang P : BMP2-SMAD signaling represses the proliferation of embryonic neural stem cells through YAP. J Neurosci. 2014;34(36):12039-48. 25186749 10.1523/JNEUROSCI.0486-14.2014
68. Lee M Ran Byun M Furutani-Seiki M : YAP and TAZ regulate skin wound healing. J Invest Dermatol. 2014;134(2):518-25. 24108406 10.1038/jid.2013.339
69. Hiemer SE Szymaniak AD Varelas X : The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells. J Biol Chem. 2014;289(19):13461-74. 24648515 10.1074/jbc.M113.529115 4036353
70. Fujii M Toyoda T Nakanishi H : TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J Exp Med. 2012;209(3):479-94. 22329991 10.1084/jem.20111653 3302232
71. Nishio M Sugimachi K Goto H : Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice. Proc Natl Acad Sci U S A. 2016;113(1):E71-80. 26699479 10.1073/pnas.1517188113 4711826
72. Szeto SG Narimatsu M Lu M : YAP/TAZ Are Mechanoregulators of TGF- β-Smad Signaling and Renal Fibrogenesis. J Am Soc Nephrol. 2016;27:3117-28. 26961347 10.1681/ASN.2015050499 5042658
73. Liu F Lagares D Choi KM : Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am J Physiol Lung Cell Mol Physiol. 2015;308(4):L344-57. 25502501 10.1152/ajplung.00300.2014 4329470
74. Pefani DE Pankova D Abraham AG : TGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation. Mol Cell. 2016;63(1):156-66. 27292796 10.1016/j.molcel.2016.05.012
75. Cichon MA Radisky DC : Cutting the brakes and flooring the gas: how TMEPAI turns TGF-β into a tumor promoter. Genes Cancer. 2014;5(9-10):303-5. 25352947 10.18632/genesandcancer.34 4209605
76. Crisan M Kartalaei PS Vink CS : BMP signalling differentially regulates distinct haematopoietic stem cell types. Nat Commun. 2015;6:8040. 26282601 10.1038/ncomms9040 4557333
77. Cook BD Evans T : BMP signaling balances murine myeloid potential through SMAD-independent p38MAPK and NOTCH pathways. Blood. 2014;124(3):393-402. 24894772 10.1182/blood-2014-02-556993 4102711
78. Zhou L Nguyen AN Sohal D : Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS. Blood. 2008;112(8):3434-43. 18474728 10.1182/blood-2008-02-139824 2569182
79. Zhao M Perry JM Marshall H : Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells. Nat Med. 2014;20(11):1321-6. 25326798 10.1038/nm.3706
80. Yamazaki S Ema H Karlsson G : Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell. 2011;147(5):1146-58. 22118468 10.1016/j.cell.2011.09.053
81. Naka K Hoshii T Muraguchi T : TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature. 2010;463(7281):676-80. 20130650 10.1038/nature08734 F1000 Recommendation
82. Leblanc R Peyruchaud O : Metastasis: new functional implications of platelets and megakaryocytes. Blood. 2016;128(1):24-31. 27154188 10.1182/blood-2016-01-636399 F1000 Recommendation
83. Labelle M Begum S Hynes RO : Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20(5):576-90. 22094253 10.1016/j.ccr.2011.09.009 3487108 F1000 Recommendation
84. Khuong-Quang DA Buczkowicz P Rakopoulos P : K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol. 2012;124(3):439-47. 22661320 10.1007/s00401-012-0998-0 3422615
85. Weller M Wick W Aldape K : Glioma. Nat Rev Dis Primers. 2015;1:15017. 27188790 10.1038/nrdp.2015.17
86. Jones C Baker SJ : Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat Rev Cancer. 2014;14(10):651-661. 25230881 10.1038/nrc3811 4747023
87. Li M Liu GH Izpisua Belmonte JC : Navigating the epigenetic landscape of pluripotent stem cells. Nat Rev Mol Cell Biol. 2012;13(8):524-35. 22820889 10.1038/nrm3393
88. Taylor KR Mackay A Truffaux N : Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet. 2014;46(5):457-61. 24705252 10.1038/ng.2925 4018681 F1000 Recommendation
89. Buczkowicz P Hoeman C Rakopoulos P : Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet. 2014;46(5):451-6. 24705254 10.1038/ng.2936 3997489 F1000 Recommendation
90. Fontebasso AM Papillon-Cavanagh S Schwartzentruber J : Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet. 2014;46(5):462-6. 24705250 10.1038/ng.2950 4282994 F1000 Recommendation
91. Zadeh G Aldape K : ACVR1 mutations and the genomic landscape of pediatric diffuse glioma. Nat Genet. 2014;46(5):421-2. 24769718 10.1038/ng.2970
92. Villanueva MT : Genetics: ACVR1 mutations-a key piece in paediatric diffuse glioma. Nat Rev Clin Oncol. 2014;11(6):300. 24840074 10.1038/nrclinonc.2014.74
93. Bagarova J Vonner AJ Armstrong KA : Constitutively active ALK2 receptor mutants require type II receptor cooperation. Mol Cell Biol. 2013;33(12):2413-24. 23572558 10.1128/MCB.01595-12 3700091
94. Shore EM Kaplan FS : Inherited human diseases of heterotopic bone formation. Nat Rev Rheumatol. 2010;6(9):518-27. 20703219 10.1038/nrrheum.2010.122 3551620